ロード中...
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers
INTRODUCTION: Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia. In the European Union, approximately 40% of people with schizophrenia have TRS. Factors such as the persistence of positive symptoms or higher risk of comorbidities leave clinicians with a complex scenario when...
保存先:
| 出版年: | BMJ Open |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2018
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6082494/ https://ncbi.nlm.nih.gov/pubmed/30012788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-021346 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|